Company news
Kangmei Pharmaceutical Co., Ltd news in 2026
Kangmei Pharmaceutical Co., Ltd's news releases, calls and decks from 2026, newest first.
(600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Holding Unrestricted Shares Concerning Share Repurchase
November 3, 2026
(600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares
November 3, 2026
(600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Progress of Litigation Involved (III)
November 2, 2026
(600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Share Repurchase Plan through Call Auction
October 28, 2026
(600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Resolutions of the 8th Extraordinary Meeting of the 10th Board of Directors in 2026
October 28, 2026
Announcement on Resolutions of the 6th Extraordinary Meeting of the 10th Board of Directors in 2026
September 7, 2026
Announcement on Convening the 2026 Semi-annual Performance Briefing
September 3, 2026
Announcement on Progress of Litigation Involved (II)
August 25, 2026
Notice on Convening the 2nd Extraordinary General Meeting in 2026
August 21, 2026
Announcement on Progress in Litigation Involved
July 20, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
June 12, 2026
Announcement on Changing Business Scope and Amending the Articles of Association
May 26, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 14, 2026
Report for Q1 2026
April 29, 2026
Announcement on Resignation of Director
April 20, 2026
Announcement on Not Planning Profit Distribution for 2025
April 17, 2026
Announcement on Transfer of Equity and Related Assets of the Wholly-owned Subsidiary
March 31, 2026
Announcement on Supplementary Payment of Taxes by the Wholly-owned Subsidiary
March 20, 2026
Announcement on Change of Signatory Certified Public Accountant and Project Quality Control Review Partner
January 9, 2026
Announcement on By-election of Members of Special Committees of the Board of Directors
January 5, 2026